H.R. 27

119th Congress

In Committee

HALT Fentanyl Act

Sponsored byRepublican:Rep. Griffith, H. Morgan [R-VA-9]VA· Introduced 3 janvier 2025
Open on Congress.gov

61

Cosponsors

16

Actions

2

Amendments

3

Committees

—

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Received in the Senate and Read twice and referred to the Committee on the Judiciary.

10 février 2025·1 year ago

Summary

Introduced in House · Updated 30 janvier 2025

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act

This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).

Additionally, the bill establishes a new, alternative registration process for certain schedule I research.

The bill also makes several other changes to registration requirements for conducting research with controlled substances, including

  • permitting a single registration for related research sites in certain circumstances,
  • waiving the requirement for a new inspection in certain situations, and
  • allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

Finally, the bill expresses the sense that Congress agrees with the interpretation of Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.

Timeline

16 actions

  1. Received in the Senate and Read twice and referred to the Committee on the Judiciary.

    10 février 2025 · IntroReferral

  2. POSTPONED PROCEEDINGS - At the conclusion of debate on the Trahan amendment No. 2, the Chair put the question on agreeing to the amendment and by voice vote, announced that the noes prevailed. Mrs. Trahan demanded the yeas and nays and the Chair postponed further proceeding until a time to be announced.

    6 février 2025 · Floor

  3. Rule provides for consideration of H.R. 27 with 1 hour of general debate. Motion to recommit allowed. The resolution makes in order only the further amendment printed in Part B of the Rules Committee report.

    6 février 2025 · Floor

  4. Considered as unfinished business. (consideration: CR H533-535)

    6 février 2025 · Floor

  5. DEBATE - Pursuant to the provisions of H. Res. 93, the House proceeded with 10 minutes of debate on the Trahan amendment No. 2.

    6 février 2025 · Floor

  6. On passage Passed by the Yeas and Nays: 312 - 108 (Roll no. 33). (text: CR H520-522)

    6 février 2025 · Floor

  7. DEBATE - The House proceeded with one hour of debate on H.R. 27.

    6 février 2025 · Floor

  8. Considered under the provisions of rule H. Res. 93. (consideration: CR H520-533)

    6 février 2025 · Floor

  9. Motion to reconsider laid on the table Agreed to without objection.

    6 février 2025 · Floor

  10. Passed/agreed to in House: On passage Passed by the Yeas and Nays: 312 - 108 (Roll no. 33). (text: CR H520-522)

    6 février 2025 · Floor

  11. Rule H. Res. 93 passed House.

    5 février 2025 · Floor

  12. Rules Committee Resolution H. Res. 93 Reported to House. Rule provides for consideration of H.R. 27 with 1 hour of general debate. Motion to recommit allowed. The resolution makes in order only the further amendment printed in Part B of the Rules Committee report.

    4 février 2025 · Floor

  13. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    3 janvier 2025 · IntroReferral

  14. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    3 janvier 2025 · IntroReferral

  15. Introduced in House

    3 janvier 2025 · IntroReferral

  16. Introduced in House

    3 janvier 2025 · IntroReferral

Sponsorship

61 cosponsors

Sponsor

Republican:Rep. Griffith, H. Morgan [R-VA-9]VA

Cosponsors

  • Democrat24%
  • Republican4896%
View all on Congress.gov

Classification

Policy area

Crime and Law Enforcement

Legislative subjects

Administrative law and regulatory proceduresDepartment of JusticeDrug trafficking and controlled substancesLicensing and registrationsResearch administration and funding

Committees

3

  • Energy and Commerce Committee

    House · Standing

    • Referred To3 Jan 2025

  • Judiciary Committee

    House · Standing

    • Referred To3 Jan 2025

  • Judiciary Committee

    Senate · Standing

    • Referred To10 Feb 2025

Amendments

2

  • HAMDT 5Failed

    6 février 2025

  • HAMDT 4Agreed

    6 février 2025

Pelosi Tracker
Follow on XRejoignez notre Discord
PolitiquesProjets de loiPortefeuillesTarifsÀ proposMentions légalesConditions d'utilisationPolitique de confidentialité
English
© 2026 - Tous droits réservés. Propulsé par Vantara Labs
Ce site web est une plateforme indépendante et tierce. Il n'est pas affilié à, approuvé par ou associé de quelque manière que ce soit à Nancy Pelosi, son bureau ou ses représentants. Toute utilisation de son nom est uniquement à des fins de discussion d'informations publiques disponibles.Les informations fournies sur ce site web sont uniquement à des fins informatives et éducatives et ne sont pas destinées à servir de conseils financiers ou d'investissement, ni ne doivent être interprétées comme tels. Les données présentées ici proviennent de déclarations et dossiers publics. Bien que nous nous efforcions d'assurer l'exactitude, l'actualité et l'exhaustivité, nous ne garantissons pas que toutes les informations sont exemptes d'erreurs ou à jour.Le support est disponible en anglais. Certaines traductions sont automatiques.